Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis)

被引:0
|
作者
Dieter Pongratz
机构
[1] Ludwig Maximilians Universität München,Friedrich
[2] Hochrhein-Institut,Baur
[3] Departement für Klinische Forschung,Institut, Medizinischen Fakultät, Neurologischen Klinik und Poliklinik
来源
Journal of Neurology | 2006年 / 253卷
关键词
dermatomyositis; polymyositis; inclusion body myositis; corticosteroids; immunosuppressives; intravenous immunoglobulins;
D O I
暂无
中图分类号
学科分类号
摘要
Polymyositis, dermatomyositis, and inclusion body myositis are idiopathic inflammatory myopathies of unknown etiology with autoimmune pathogenesis. For choosing an individual and efficient therapy, diagnostic assignment is an important factor. Therapeutic options in dermatomyositis and polymyositis include corticosteroids and immunosuppressives. Intravenous immunoglobulins are only needed in special cases. In inclusion body myositis, corticosteroids and immunosuppressives are not successful. At the moment intravenous immunoglobulins are the only therapeutic possibility.
引用
收藏
页码:v64 / v65
相关论文
共 50 条